ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Forgot password
  • Home
  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

21 May 2020 10:32 AM | Daniel Hawley (Administrator)

Original Paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext

Wang y, et al.  
April 2020, accessed May 3, 2020

View Journal Club Review


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888 • sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software